Anders Martin-Löf

Finanzdirektor/CFO bei BIOARCTIC AB

Vermögen: 15 197 $ am 30.04.2024

53 Jahre

83 Beziehungen

Health Technology

Consumer Services

Technology Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Lars Gunnar Lannfelt	M	75	BIOARCTIC AB	21 Jahre
Pär Lars Gellerfors	M	77	BIOARCTIC AB	21 Jahre
Sofia Heigis	F	44	ONCOPEPTIDES AB	4 Jahre
Eugen Steiner	M	70	BIOARCTIC AB	7 Jahre
Göran Forsberg	M	61	CANTARGIA AB	10 Jahre
Thoas Michael Fioretos	M	66	CANTARGIA AB	15 Jahre
Karolina Vilval	F	45	ONCOPEPTIDES AB Oncopeptides Incentive AB	3 Jahre
Patricia Delaite	M	61	CANTARGIA AB	7 Jahre
Flavia Borellini	M	64	CANTARGIA AB	4 Jahre
Karin Leandersson	F	52	CANTARGIA AB	8 Jahre
Gunilla Christina Osswald	M	63	BIOARCTIC AB	11 Jahre
Jan Mattsson	M	64	BIOARCTIC AB	7 Jahre
Jennifer Jackson	M	71	ONCOPEPTIDES AB	6 Jahre
Joachim Feldwisch	M	-	Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	-
Martin Duvall	M	62	ONCOPEPTIDES AB Oncopeptides Incentive AB	2 Jahre
Charlotta Ljungqvist	M	63	BIOARCTIC AB	3 Jahre
Stig Anders Lindberg	M	52	Oncopeptides Incentive AB Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	-
Carl Erik Mathias Uhlén	M	70	Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	26 Jahre
Karin Nord	M	-	Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	26 Jahre
Magnus Nilsson	M	68	CANTARGIA AB	3 Jahre
Gunnar Magnus Modee Persson	M	64	CANTARGIA AB	8 Jahre
Oskar Bosson	M	48	BIOARCTIC AB	4 Jahre
Åke Mikael Smedeby	M	56	BIOARCTIC AB	6 Jahre
Damian Marron	M	62	CANTARGIA AB	3 Jahre
Jose F. Suarez	M	54	Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	-
Lars Thorsson	M	63	CANTARGIA AB	9 Jahre
Patrik Renblad	M	54	CANTARGIA AB	1 Jahre
Camilla Soenderby	F	-	Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	-
Anna-Kaija Grönblad	F	56	BIOARCTIC AB	3 Jahre
Liselotte Larsson	M	61	CANTARGIA AB	10 Jahre
Lotta Larsson	F	-	RAYSEARCH LABORATORIES AB	14 Jahre
Gunilla Andersson	F	63	BIOARCTIC AB	5 Jahre
David Liberg	M	55	CANTARGIA AB	9 Jahre
Johanna Fälting	M	52	BIOARCTIC AB	12 Jahre
Lars Jordeby	M	59	RAYSEARCH LABORATORIES AB	10 Jahre
David Bejker	M	49	Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	6 Jahre
Cecilia Marie Edström	F	58	BIOARCTIC AB	1 Jahre
Alan Hulme	M	-	Oncopeptides Incentive AB	-
Christer Möller	M	65	BIOARCTIC AB	18 Jahre
Robert Forbes Burns	M	77	Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	-
Dominique Tersago	M	62	CANTARGIA AB	2 Jahre
Tomas Odergren	M	65	BIOARCTIC AB	5 Jahre
Peter Kemlin	M	50	RAYSEARCH LABORATORIES AB	12 Jahre
Nedjad Losic	M	54	CANTARGIA AB	3 Jahre
J. Kenneth Charles Knowles	M	77	Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.	-

Mehr sehen

Beziehungs-Chart

Beziehungen zu mehreren Unternehmen

Ehemalige Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Wenche Nelly A. Rolfsen Sandsborg	M	72	BIOARCTIC AB	7 Jahre
Mats Gunnar Pettersson	M	78	SWEDISH ORPHAN BIOVITRUM AB	6 Jahre
Lennart Rolf Ivar Verner	M	77	BIOARCTIC AB	14 Jahre
Victoria Sörving	F	38	RAYSEARCH LABORATORIES AB	-
Bengt Håkan Englund	M	72	BIOARCTIC AB	4 Jahre
Bali Muralidhar	M	44	WILSON THERAPEUTICS AB	4 Jahre
Björn Ingemar Odlander	M	66	WILSON THERAPEUTICS AB	-
Peter Thysell	M	54	RAYSEARCH LABORATORIES AB	6 Jahre
Birgitte Volck	M	61	WILSON THERAPEUTICS AB	1 Jahre
Sylvain Forget	M	58	SWEDISH ORPHAN BIOVITRUM AB	-
Anders Edvell	M	55	SWEDISH ORPHAN BIOVITRUM AB	-
Marten Steen	M	49	WILSON THERAPEUTICS AB	5 Jahre
Johannes G. C. P. Schikan	M	66	WILSON THERAPEUTICS AB	3 Jahre
Rolf Gulliksen	M	65	ONCOPEPTIDES AB	3 Jahre
Dina Chaya	M	52	WILSON THERAPEUTICS AB	3 Jahre
Alf Gunnar Martin Nicklasson	M	69	SWEDISH ORPHAN BIOVITRUM AB	3 Jahre
Andrew Kay	M	69	WILSON THERAPEUTICS AB	-
Vincent Metzler	M	-	WILSON THERAPEUTICS AB	-
Ignacio Garcia-Ribas	M	-	CANTARGIA AB	2 Jahre
Peter Juul Madsen	M	-	CANTARGIA AB	2 Jahre
Karin Eklund Vanderpol	F	51	ONCOPEPTIDES AB	2 Jahre
Susanne Lagerlund	F	56	CANTARGIA AB	3 Jahre
Klaas Bakker	M	42	ONCOPEPTIDES AB	-
Roger Belusa	M	-	CANTARGIA AB	-
Corinne Savill	M	64	CANTARGIA AB	-
Christian Jacques	M	68	ONCOPEPTIDES AB	2 Jahre
Bengt Jöndell	M	64	CANTARGIA AB	6 Jahre
Rick Lilley	M	67	WILSON THERAPEUTICS AB	2 Jahre
Linda Holmström	F	-	ONCOPEPTIDES AB	-
Elisabeth Augustsson	F	59	ONCOPEPTIDES AB	5 Jahre
Jonas Karl Hansson	M	50	WILSON THERAPEUTICS AB	6 Jahre
Annika Muskantor	F	58	ONCOPEPTIDES AB	2 Jahre
Karin Birgitta Margareta Ståhl	F	53	ONCOPEPTIDES AB	2 Jahre
Claus Asbjørn Andersson	M	56	CANTARGIA AB	8 Jahre
Mats-Olof Ljungquist	M	72	SWEDISH ORPHAN BIOVITRUM AB	3 Jahre
Rein Piir	M	66	ONCOPEPTIDES AB	4 Jahre
Johan Georg Harmenberg	M	70	ONCOPEPTIDES AB	7 Jahre
Han Jing Xie	M	54	ONCOPEPTIDES AB	2 Jahre

Statistik

Land	Beziehungen	% des Gesamten
Schweden	83	100,00%

Alter der Beziehungen

Aktive

Vergangene

Herr

Frau

Aufsichtsräte

Führungskräfte

Ursprung der Beziehungen

Börse
Insiders
Anders Martin-Löf
Persönliches Netzwerk